Trial Profile
Phase 1 clinical trial in healthy human volunteers to determine the safety, tolerability and pharmacokinetics of GS-5734
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2015
Price :
$35
*
At a glance
- Drugs Remdesivir (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 26 Oct 2015 New trial record